drugset / Trial / NCT00527085
12-month Study of AMG 073 in Renal Osteodystrophy
RandomizedParallel-groupTriple-blindTreatment
Summary
4 doses of AMG 073 or placebo over 52 weeks after a 30-day screening period. Throughout the study, labs will be drawn to measure analytes such as iPTH and corrected calcium. In addition, a bone biopsy will be performed at screening and at the end of study.
Timeline
- Start
- 2001-10
- Primary completion
- 2003-08
- Completion
- 2003-08
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Cinacalcet | Other / unclassified | 30 mg | Oral |
| Subject | Cinacalcet | Other / unclassified | 50 mg | Oral |
| Subject | Cinacalcet | Other / unclassified | 70 mg | Oral |
| Subject | Cinacalcet | Other / unclassified | 90 mg | Oral |
| Subject | Cinacalcet | Other / unclassified | 120 mg | Oral |
| Subject | Cinacalcet | Other / unclassified | 180 mg | Oral |